Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of AdCh63 and MVA Malaria Vaccines
NCT01142765Phase 2Completed
- Sponsor
- University of Oxford
- Start
- Jun 2010
- Primary completion
- Mar 2011
- Modality
- Viral Vector Vaccines, Viral Vectors, DNA Vaccines
- Countries
- 1
01
Overview
Phase 2, open-label trial of adch63 ama1, MVA AMA1 vaccine, AdCh63 MSP1, mva msp1 vaccine, ChAd63 ME-TRAP and 1 more in malaria, sponsored by University of Oxford. Started Jun 2010; status: completed.
02
Drugs
adch63 ama1MVA AMA1 vaccineAdCh63 MSP1mva msp1 vaccineChAd63 ME-TRAP
03
Conditions
malaria
Beyond the preview
Go deeper on NCT01142765.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01142765.